84-5357-64 ［取扱停止］IRF2BP2 100ul 530917
特徴
- Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427).
- Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369).
- Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774).
- Plays a role in immature B-cell differentiation (PubMed:27016798).
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:2000Optimal dilutions to be determined by the researcher.
- Positive Control:mouse spleen, mouse lung
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ul
- Host：rabbit
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by affinity chromatography.
- Form：Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
- Specificity：Recognizes human IRF2BP2. Species Crossreactivity: mouse
- Isotype：IgG
- Calc Applications Abbrev：WB
- Calc Crossreactivity：Hu Mo
- Immunogen：Recombinant protein corresponding to human IRF2BP2.
- Swiss Prot Number：Q7Z5L9
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
